The antitumor lignan Nortrachelogenin sensitizes prostate cancer cells to TRAIL-induced cell death by inhibition of the Akt pathway and growth factor signaling

Emilia Peuhu, Preethy Paul, Mika Remes, Thomas Holmbom, Patrik Eklund, Rainer Sjöholm, John E. Eriksson

Biochemical Pharmacology (2013)

Published on December 4, 2025

DOI: https://doi.org/10.1016/j.bcp.2013.05.026

← Back to Publications